AtriCure Reports First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
AtriCure Inc. (ATRC) PT Raised to $81 at Needham & Company
April 28, 2021 6:20 AM EDTNeedham & Company analyst Mike Matson raised the price target on AtriCure Inc. (NASDAQ: ATRC) to $81.00 (from $74.00) while maintaining a Buy rating.
The analyst commented, "ATRC's 1Q21 revenue, adjusted EBITDA, and adjusted EPS all beat consensus. The impact from the pandemic eased during the... More
AtriCure (ATRC) Tops Q1 EPS by 5c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus
April 27, 2021 4:06 PM EDTAtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.32), $0.05 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $59.3 million versus the consensus estimate of $56.06 million.
Our growth in the first quarter is a testament of our teams strong execution and unwavering dedication... More
